MarketPeel
Insider Trading Intelligence
TI

Talat Imran

RANI
CHIEF EXECUTIVE OFFICER · RANI THERAPEUTICS HOLDINGS, INC. · CIK 0001869579
FILING MIX · LIFETIME76%/24%
BUYS
19
SELLS
6
TOTAL VALUE
$154.0K
COMPANIES
1
ACTIVE SINCE
Sep 2021
HOLDINGS NOW
3,800,000
AVG SELL PX
$5.95
TRADE KIND
SHOWING 25 / 25
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
6 backtested trades · 8 horizons · 1 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Talat Imran, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d6+50.00%+12.47%+1.73%+10.74%+6.12%
14d6+83.33%+11.23%+2.80%+8.43%+3.58%
30d6+83.33%+24.65%+3.15%+21.50%+24.59%
60d6+83.33%+41.37%+6.78%+34.59%+40.33%
90d6+83.33%+53.37%+9.33%+44.05%+50.13%
180d6+83.33%+138.61%+14.74%+123.87%+109.80%
1y6+50.00%-2.71%+31.77%-34.48%-32.41%
2y6(1 pending)+40.00%-12.31%+54.57%-66.87%-71.28%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
RANI · 3,800,000 shares · as of Jun 3, 2026
0950,0001,900,0002,850,0003,800,00020222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 19 buys / 6 sellsCOVERAGE · 20 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
RANI
RANI THERAPEUTICS HOLDINGS, INC.
PURCHASEGRANT
Stock grant
3,800,0003,800,000Jun 3, 2026Jun 5, 2026View →
RANI
RANI THERAPEUTICS HOLDINGS, INC.
PURCHASEGRANT
Stock grant
1,053,0001,053,000May 23, 2025May 23, 2025View →
RANI
RANI THERAPEUTICS HOLDINGS, INC.
PURCHASE
Chief Executive Officer
10,296$1.94$20.0K494,751Dec 9, 2024Dec 10, 2024View →
RANI
RANI THERAPEUTICS HOLDINGS, INC.
PURCHASEGRANT
Stock grant
1,085,0001,085,000Mar 21, 2024Mar 22, 2024View →
RANI
RANI THERAPEUTICS HOLDINGS, INC.
PURCHASEGRANT
Stock grant
271,875271,875Dec 16, 2023Dec 19, 2023View →
RANI
RANI THERAPEUTICS HOLDINGS, INC.
PURCHASEGRANT
Stock grant
31,25231,252Dec 16, 2023Dec 19, 2023View →
RANI
RANI THERAPEUTICS HOLDINGS, INC.
SALE
Chief Executive Officer
271,875453,125Dec 16, 2023Dec 19, 2023View →
RANI
RANI THERAPEUTICS HOLDINGS, INC.
SALE
Chief Executive Officer
153,650109,750Dec 16, 2023Dec 19, 2023View →
RANI
RANI THERAPEUTICS HOLDINGS, INC.
PURCHASEGRANT
Stock grant
153,650153,650Dec 16, 2023Dec 19, 2023View →
RANI
RANI THERAPEUTICS HOLDINGS, INC.
SALE
Chief Executive Officer
479,66795,933Dec 16, 2023Dec 19, 2023View →
RANI
RANI THERAPEUTICS HOLDINGS, INC.
SALE
Chief Executive Officer
31,25247,699Dec 16, 2023Dec 19, 2023View →
RANI
RANI THERAPEUTICS HOLDINGS, INC.
PURCHASEGRANT
Stock grant
479,667479,667Dec 16, 2023Dec 19, 2023View →
RANI
RANI THERAPEUTICS HOLDINGS, INC.
PURCHASE
Chief Executive Officer
10,000$2.27$22.7K484,455Dec 6, 2023Dec 7, 2023View →
RANI
RANI THERAPEUTICS HOLDINGS, INC.
PURCHASE
Chief Executive Officer
5,000$2.57$12.8K474,455Dec 4, 2023Dec 6, 2023View →
RANI
RANI THERAPEUTICS HOLDINGS, INC.
PURCHASE
Chief Executive Officer
20,000$2.05$41.0K469,455Nov 29, 2023Dec 1, 2023View →
RANI
RANI THERAPEUTICS HOLDINGS, INC.
PURCHASE
Chief Executive Officer
2,500$2.01$5.0K449,455Nov 7, 2023Nov 9, 2023View →
RANI
RANI THERAPEUTICS HOLDINGS, INC.
PURCHASE
Chief Executive Officer
2,500$1.98$5.0K446,955Nov 7, 2023Nov 9, 2023View →
RANI
RANI THERAPEUTICS HOLDINGS, INC.
PURCHASEGRANT
Stock grant
575,600575,600Mar 27, 2023Mar 29, 2023View →
RANI
RANI THERAPEUTICS HOLDINGS, INC.
PURCHASEGRANT
Stock grant
353,500444,445Mar 27, 2023Mar 29, 2023View →
RANI
RANI THERAPEUTICS HOLDINGS, INC.
SALE
CEO
7,988$5.95$47.5K90,945Mar 22, 2023Mar 24, 2023View →
RANI
RANI THERAPEUTICS HOLDINGS, INC.
PURCHASEGRANT
Stock grant
86,60098,943Mar 22, 2022Mar 24, 2022View →
RANI
RANI THERAPEUTICS HOLDINGS, INC.
PURCHASEGRANT
Stock grant
263,400263,400Mar 22, 2022Mar 24, 2022View →
RANI
RANI THERAPEUTICS HOLDINGS, INC.
SALE
Chief Executive Officer
827,4670Feb 3, 2022Feb 7, 2022View →
RANI
RANI THERAPEUTICS HOLDINGS, INC.
PURCHASE
Chief Executive Officer
12,34312,343Feb 3, 2022Feb 7, 2022View →
RANI
RANI THERAPEUTICS HOLDINGS, INC.
PURCHASEGRANT
Stock grant
725,000725,000Sep 9, 2021Sep 13, 2021View →
Other insiders · RANI
Loading peer insiders…
About this filer
CIK 0001869579
ROLE
Chief Executive Officer
PRIMARY
RANI
COMPANIES
1
ACTIVE SINCE
Sep 2021
MARKETPEEL · /INSIDER/0001869579DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback